Our group [7] applied a theranostic approach of [68Ga]Ga guided [177Lu]Lu-DOTA.SA.FAPi therapy in an advanced stage breast cancer (histology status: ER−, PR−, HER2/neu+) patient who failed multiple lines of treatment, and demonstrated a promising improvement in the quality of life. This evidence concerns the gene ERBB2 and breast cancer.